Literature DB >> 27031540

Comparison of femtosecond and excimer laser platforms available for corneal refractive surgery.

Lisa Y Chen1, Edward E Manche.   

Abstract

PURPOSE OF REVIEW: The evolution of laser technology has left today's refractive surgeon with a choice between multiple laser platforms. The purpose of this review is to compare currently available femtosecond and excimer laser platforms, providing a summary of current evidence. RECENT
FINDINGS: Femtosecond lasers create LASIK flaps with better accuracy, uniformity, and predictability than mechanical microkeratomes. Newer higher-frequency femtosecond platforms elicit less inflammation, producing better visual outcomes. SMILE achieved similar safety, efficacy, and predictability as LASIK with greater preservation of corneal nerves and biomechanical strength. The emergence of wavefront technology has resulted in improved excimer laser treatments. Comparisons of wavefront-guided and wavefront-optimized treatments suggest that there is an advantage to using wavefront-guided platforms in terms of visual acuity and quality of vision. Topography-guided ablations are another well tolerated and effective option, especially in eyes with highly irregular corneas.
SUMMARY: Advances in femtosecond and excimer laser technology have not only improved the safety and efficacy of refractive procedures, but have also led to the development of promising new treatment modalities, such as SMILE and the use of wavefront-guided and topography-guided ablation. Future studies and continued technological progress will help to better define the optimal use of these treatment platforms.

Entities:  

Mesh:

Year:  2016        PMID: 27031540     DOI: 10.1097/ICU.0000000000000268

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  7 in total

1.  Laser surface modification of decellularized extracellular cartilage matrix for cartilage tissue engineering.

Authors:  Eva Goldberg-Bockhorn; Silke Schwarz; Rachana Subedi; Alexander Elsässer; Ricarda Riepl; Paul Walther; Ludwig Körber; Roman Breiter; Karl Stock; Nicole Rotter
Journal:  Lasers Med Sci       Date:  2017-12-06       Impact factor: 3.161

2.  Blue-LIRIC in the rabbit cornea: efficacy, tissue effects, and repetition rate scaling.

Authors:  Ruiting Huang; Dan Yu; Daniel Savage; Kaitlin Wozniak; Len Zheleznyak; Wayne H Knox; Krystel R Huxlin
Journal:  Biomed Opt Express       Date:  2022-03-22       Impact factor: 3.562

3.  Predictive Factors for Successful High Myopia Treatment Using High-Frequency Laser-In-Situ Keratomileusis.

Authors:  Widya Artini; Setyo B Riyanto; Johan A Hutauruk; Tjahjono D Gondhowiardjo; Aria Kekalih
Journal:  Open Ophthalmol J       Date:  2018-07-23

4.  Correlation between higher-order aberrations and visual acuity recovery (CoHORT) after spectacles treatment for pediatric refractive amblyopia: A pilot study using iDesign measurement.

Authors:  Chun-Fu Liu; Chung-Hsin Tseng; Chung-Ying Huang; Chi-Chin Sun; Meng-Ling Yang; Wei-Yi Chen; Ling Yeung
Journal:  PLoS One       Date:  2020-02-14       Impact factor: 3.240

5.  Contralateral Posterior Chamber Phakic Intraocular Lens Implantation as Rehabilitation of Refractive Lens Exchange with a Monofocal Intraocular Lens in a Young, Nonpresbyopic, Bilateral Highly-Myopic Patient.

Authors:  Kepa Balparda; Claudia Marcela Vanegas-Ramírez; Laura Segura-Muñoz; Manuela Gómez-Londoño
Journal:  Case Rep Ophthalmol Med       Date:  2019-10-16

6.  Optical Coherence Tomography-Guided Femtosecond LASIK in the Setting of Corneal Scarring.

Authors:  Sloan W Rush; Ryan B Rush
Journal:  Clin Ophthalmol       Date:  2021-04-20

7.  Effect of Myopic Femtosecond Laser-Assisted LASIK on Anterior Chamber Inflammation (Flare Values) and Corneal Endothelium: A Prospective before and after Study.

Authors:  Kemal Turgay Özbilen; Emre Altinkurt; Nihan Aksu Ceylan; Gizem Sayar Bilgin; Nilüfer Gözüm
Journal:  J Ophthalmol       Date:  2021-11-26       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.